EHRs Become A Stronger Research Tool Under Proposed Stage 2 Meaningful Use Rule
Use of electronic health records to report data to disease registries, for both cancer and non-cancer conditions, becomes an optional objective for providers to demonstrate “meaningful use” of EHRs under CMS’ proposed stage 2 requirements. An objective to identify patients for potential research opportunities also carries over to the stage 2 proposal.
You may also be interested in...
Patient-Centered Outcomes Research Institute selected five drug-related research topics for funding, including a look at narrow- versus broad-spectrum antibiotics for acute respiratory tract infections in children, though all studies are observational. PCORI approved 52 CER projects in this third funding round, including many declined in the first round.
While facilitating research is not necessarily Surescripts’ main goal as it transitions its network infrastructure from an e-prescribing-related data exchange to enabling more health information exchange, SVP Miller says the network could play a role in helping research benefit from the growth in health information technology.
Agency gives eligible physicians and hospitals that started earning incentive payments for the meaningful use of electronic health records in 2011 an additional year, until 2014, to begin demonstrating that they are meeting the standards outlined in the recently finalized rule.